logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 4
  • 1
    Colgan, Erin
    Born in May 1980
    Individual (1 offspring)
    Officer
    2025-03-19 ~ 2026-04-24
    OF - Director → CIF 0
  • 2
    Chapman, Marcus Andrew, Mr.
    Finance born in November 1970
    Individual (2 offsprings)
    Officer
    2022-04-12 ~ 2025-03-19
    OF - Director → CIF 0
  • 3
    Keefe, Susan, Ms.
    Born in November 1972
    Individual (1 offspring)
    Officer
    2026-04-24 ~ now
    OF - Director → CIF 0
  • 4
    QUOTIENT THERAPEUTICS LIMITED - now
    FLAGSHIP LABS 86 UK, LTD - 2023-08-23 14042800
    55 Cambridge Parkway, Suite 800e, Cambridge, Ma, United States
    Active Corporate (4 parents, 1 offspring)
    Person with significant control
    2022-04-12 ~ 2022-04-12
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
parent relation
Company in focus

QUOTIENT THERAPEUTICS LIMITED

Period: 2023-08-23 ~ now
Company number: 14042800
Registered names
QUOTIENT THERAPEUTICS LIMITED - now
Recent Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
342024-01-01 ~ 2024-12-31
182023-01-01 ~ 2023-12-31
Property, Plant & Equipment
1,524,437 GBP2024-12-31
691,040 GBP2023-12-31
Debtors
Non-current
183,286 GBP2024-12-31
183,286 GBP2023-12-31
Current
3,144,234 GBP2024-12-31
2,018,028 GBP2023-12-31
Cash at bank and in hand
814,410 GBP2024-12-31
738,817 GBP2023-12-31
Current Assets
4,141,930 GBP2024-12-31
2,940,131 GBP2023-12-31
Net Current Assets/Liabilities
2,684,119 GBP2024-12-31
1,769,882 GBP2023-12-31
Total Assets Less Current Liabilities
4,208,556 GBP2024-12-31
2,460,922 GBP2023-12-31
Creditors
Non-current, Amounts falling due after one year
-351,982 GBP2023-12-31
Net Assets/Liabilities
3,399,832 GBP2024-12-31
1,940,885 GBP2023-12-31
Equity
Called up share capital
1 GBP2024-12-31
1 GBP2023-12-31
1 GBP2023-01-01
Other miscellaneous reserve
985,229 GBP2024-12-31
985,229 GBP2023-12-31
407,581 GBP2023-01-01
Retained earnings (accumulated losses)
2,414,602 GBP2024-12-31
955,655 GBP2023-12-31
19,955 GBP2023-01-01
Equity
3,399,832 GBP2024-12-31
1,940,885 GBP2023-12-31
427,537 GBP2023-01-01
Profit/Loss
Retained earnings (accumulated losses)
1,394,515 GBP2024-01-01 ~ 2024-12-31
915,731 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
1,394,515 GBP2024-01-01 ~ 2024-12-31
915,731 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
1,394,515 GBP2024-01-01 ~ 2024-12-31
915,731 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
1,394,515 GBP2024-01-01 ~ 2024-12-31
915,731 GBP2023-01-01 ~ 2023-12-31
Equity - Income/Expense Recognised Directly
Retained earnings (accumulated losses)
64,432 GBP2024-01-01 ~ 2024-12-31
19,969 GBP2023-01-01 ~ 2023-12-31
Equity - Income/Expense Recognised Directly
64,432 GBP2024-01-01 ~ 2024-12-31
597,617 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
1,732,555 GBP2024-12-31
706,491 GBP2023-12-31
Furniture and fittings
102,069 GBP2024-12-31
91,864 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
1,915,338 GBP2024-12-31
798,355 GBP2023-12-31
Computers
17,514 GBP2024-12-31
Other
63,200 GBP2024-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
97,687 GBP2023-12-31
Furniture and fittings
9,628 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
107,315 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Owned/Freehold
75,027 GBP2024-01-01 ~ 2024-12-31
Under hire purchased contracts or finance leases, Plant and equipment
208,559 GBP2024-01-01 ~ 2024-12-31
Under hire purchased contracts or finance leases
208,559 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
365,231 GBP2024-12-31
Furniture and fittings
23,724 GBP2024-12-31
Computers
1,946 GBP2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
390,901 GBP2024-12-31
Property, Plant & Equipment
Plant and equipment
1,367,324 GBP2024-12-31
608,804 GBP2023-12-31
Furniture and fittings
78,345 GBP2024-12-31
82,236 GBP2023-12-31
Computers
15,568 GBP2024-12-31
Other
63,200 GBP2024-12-31
Plant and equipment, Under hire purchased contracts or finance leases
1,087,484 GBP2024-12-31
432,264 GBP2023-12-31
Other Debtors
Non-current
183,286 GBP2024-12-31
183,286 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
348 GBP2024-12-31
Amounts Owed by Group Undertakings
Current
1,199,594 GBP2024-12-31
790,523 GBP2023-12-31
Other Debtors
Current
1,752,288 GBP2024-12-31
1,044,810 GBP2023-12-31
Prepayments/Accrued Income
Current
192,004 GBP2024-12-31
182,695 GBP2023-12-31
Trade Creditors/Trade Payables
Current
112,605 GBP2024-12-31
339,795 GBP2023-12-31
Amounts owed to group undertakings
Current
6,416 GBP2024-12-31
Finance Lease Liabilities - Total Present Value
Current
294,718 GBP2024-12-31
107,772 GBP2023-12-31
Other Creditors
Current
60,822 GBP2024-12-31
59,574 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
983,250 GBP2024-12-31
663,108 GBP2023-12-31
Creditors
Current
1,457,811 GBP2024-12-31
1,170,249 GBP2023-12-31
Finance Lease Liabilities - Total Present Value
Non-current
329,776 GBP2024-12-31
167,880 GBP2023-12-31
Other Creditors
Non-current
124,785 GBP2024-12-31
184,102 GBP2023-12-31
Creditors
Non-current
454,561 GBP2024-12-31
351,982 GBP2023-12-31
Minimum gross finance lease payments owing
624,494 GBP2024-12-31
275,652 GBP2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
610,454 GBP2024-12-31
610,454 GBP2023-12-31
Between one and five year
1,113,365 GBP2024-12-31
1,723,819 GBP2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
1,723,819 GBP2024-12-31
2,334,273 GBP2023-12-31
Related profiles found in government register
  • QUOTIENT THERAPEUTICS LIMITED
    Info
    FLAGSHIP LABS 86 UK, LTD - 2023-08-23
    Registered number 14042800
    Suite 4, 7th Floor 50 Broadway, London SW1H 0DB
    PRIVATE LIMITED COMPANY incorporated on 2022-04-12 (4 years 6 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-04-12
    CIF 0
  • FLAGSHIP LABS 86, INC.
    S
    Registered number 111
    55 Cambridge Parkway, Suite 800e, Cambridge, Ma, United States, 02142
    Incorporated in Usa
    CIF 1
child relation
Offspring entities and appointments 1
  • 1
    QUOTIENT THERAPEUTICS LIMITED - now
    FLAGSHIP LABS 86 UK, LTD
    - 2023-08-23 14042800
    Suite 4, 7th Floor 50 Broadway, London, United Kingdom
    Active Corporate (4 parents, 1 offspring)
    Person with significant control
    2022-04-12 ~ 2022-04-12
    CIF 1 - Right to appoint or remove directors → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Ownership of shares – 75% or more → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 14 July 2026 and licensed under the Open Government Licence v3.0.